Rogel Cancer Center, University of Michigan — Ann Arbor, Michigan

Rogel Cancer Center, University of Michigan is a clinical research site located in Ann Arbor, Michigan, United States 48109-0944.

Crixeo Clinical Trials Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

Rogel Cancer Center, University of Michigan has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8.

Sponsors: Blue Note Therapeutics, OncoC4, Inc., Daiichi Sankyo.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Ann Arbor

Browse all research sites in Michigan · View every site in Ann Arbor

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rogel Cancer Center, University of Michigan?

Rogel Cancer Center, University of Michigan has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rogel Cancer Center, University of Michigan conducted?

Rogel Cancer Center, University of Michigan has 3 clinical trials on record, with 1 currently active. Their work covers Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8.

Is Rogel Cancer Center, University of Michigan accredited by Crixeo Clinical Trials?

Rogel Cancer Center, University of Michigan has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rogel Cancer Center, University of Michigan?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.